Interleukin-6 Is a Novel Factor Mediating Glucose Homeostasis During Skeletal Muscle Contraction
Top Cited Papers
- 1 July 2004
- journal article
- clinical trial
- Published by American Diabetes Association in Diabetes
- Vol. 53 (7) , 1643-1648
- https://doi.org/10.2337/diabetes.53.7.1643
Abstract
The mechanisms that mediate the tightly controlled production and clearance of glucose during muscular work are unclear, and it has been suggested that an unidentified “work factor” exists that influences the contraction-induced increase in endogenous glucose production (EGP). The cytokine interleukin (IL)-6 is released from skeletal muscle during contraction. Here we show that IL-6 contributes to the contraction-induced increase in EGP. Six men performed 2 h of bicycle exercise on three separate occasions, at a relatively high intensity (HI) or at a low intensity with (LO + IL-6) or without (LO) an infusion of recombinant human IL-6 that matched the circulating concentration of IL-6 seen in HI exercise. The stable isotope 6,6 2H2 glucose was infused to calculate EGP (rate of glucose appearance [Ra]), whole-body glucose disposal (rate of glucose disappearance [Rd]), and metabolic clearance rate (MCR) of glucose. Glucose Ra, Rd, and MCR were higher (P < 0.05) at HI than at LO. Throughout exercise at LO + IL-6, glucose Ra and Rd were higher (P < 0.05) than LO, even though the exercise intensity was identical. In addition, MCR was higher (P < 0.05) at LO + IL-6 than at LO at 90 min. Insulin, glucagon, epinephrine, norepinephrine, cortisol, and growth hormone were identical when comparing LO + IL-6 with LO. These data suggest that IL-6 influences glucose homeostasis during exercise. Our results provide potential new insights into factors that mediate glucose production and disposal and implicates IL-6 in the so-called “work factor.”Keywords
This publication has 27 references indexed in Scilit:
- Exercise and IL‐6 infusion inhibit endotoxin‐induced TNF‐α production in humansThe FASEB Journal, 2003
- Muscle‐derived interleukin‐6: mechanisms for activation and possible biological rolesThe FASEB Journal, 2002
- Muscle‐derived interleukin‐6: possible biological effectsThe Journal of Physiology, 2001
- Interleukins and exerciseThe Journal of Physiology, 2000
- Glucoregulation during and after intense exercise: Effects of α-adrenergic blockadeMetabolism, 2000
- Effect of adrenaline on glucose kinetics during exercise in adrenalectomised humansThe Journal of Physiology, 1999
- Interleukin 1β and interleukin 6, but not tumor necrosis factor α, inhibit insulin-stimulated glycogen synthesis in rat hepatocytesHepatology, 1998
- Dose-Dependent Effects of Recombinant Human Interleukin-6 on Glucose RegulationJournal of Clinical Endocrinology & Metabolism, 1997
- Interleukin-6 Enhances Glucose Transport in 3T3-L1 AdipocytesBiochemical and Biophysical Research Communications, 1996
- Glucoregulation during and after intense exercise: effects of beta- blockadeJournal of Clinical Endocrinology & Metabolism, 1994